Basal Insulin Titration Guidelines

Initial Dosing Strategy

The American Diabetes Association recommends starting with 10 units once daily or 0.1-0.2 units/kg/day for insulin-naive patients with type 2 diabetes, administered at the same time each day 3, 1, 2
For patients with severe hyperglycemia, consider higher starting doses of 0.3-0.4 units/kg/day or immediate basal-bolus regimen, as suggested by the American Association of Clinical Endocrinologists 2, 3
Continue metformin unless contraindicated, and possibly one additional non-insulin agent, as recommended by the European Association for the Study of Diabetes 1, 2

Increase by 4 units every 3 days if fasting glucose ≥180 mg/dL, as recommended by the American Diabetes Association 3
Increase by 2 units every 3 days if fasting glucose is 140-179 mg/dL, based on guidelines from the American Association of Clinical Endocrinologists 3
Target fasting plasma glucose of 80-130 mg/dL, as suggested by the International Diabetes Federation 3
If hypoglycemia occurs, reduce dose by 10-20% immediately, as recommended by the American Diabetes Association 3

When basal insulin exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day, stop escalating and add prandial insulin or GLP-1 RA instead, as suggested by the European Association for the Study of Diabetes 5, 3
Clinical signals of "overbasalization" include bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia, high glucose variability, and basal dose >0.5 units/kg/day, as identified by the American Association of Clinical Endocrinologists 3

Add a GLP-1 receptor agonist or dual GIP/GLP-1 RA if basal insulin has been titrated to acceptable fasting glucose but A1C remains above target after 3-6 months, as recommended by the American Diabetes Association 5, 3
Alternatively, add prandial insulin, starting with 4 units of rapid-acting insulin before the largest meal or 10% of current basal dose, as suggested by the International Diabetes Federation 5, 3

Daily fasting blood glucose monitoring is essential during the titration phase, as recommended by the American Association of Clinical Endocrinologists 3
Assess adequacy of insulin dose at every clinical visit, specifically looking for signs of overbasalization, as suggested by the European Association for the Study of Diabetes 3

Never delay titration, as waiting longer than 3 days between adjustments in stable patients unnecessarily prolongs time to glycemic targets, as warned by the American Diabetes Association 4
Never continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia, as cautioned by the American Association of Clinical Endocrinologists 3, 4
Never stop metformin when adding or intensifying insulin therapy unless contraindicated, as recommended by the International Diabetes Federation 5, 3, 4